Intravenous injection of non-neurotoxic plasminogen activators for the treatment of stroke

摘要

The invention relates to the use of non-neurotoxic plasminogen-activating factors, e.g. from Desmodus rotundus (DSPA) or genetically modified plasminogen-activating factors especially of human origin, for producing a therapeutic agent that is to be injected for the therapeutic treatment of stroke in humans.